Novel drug therapy targeting NF-kB signal for triple-negative breast cancer patients with loss of CYLD expression

○Hitomi Arakaki

5:24 PM - 5:36 PM

[26PS3-pm16S] Novel drug therapy targeting NF-kB signal for triple-negative breast cancer patients with loss of CYLD expression

○Hitomi Arakaki¹, Akari Kuwano¹, Chika Hirai¹, Chica Saigo², Ayumi Kanemaru¹, Mitsuhiro Hayashi³, Hideyuki Saito^1,2, Yuki Narita^1,2, Hirofumi Jono^1,2 (1. Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University., 2. Department of Pharmacy, Kumamoto University Hospital., 3. Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[26PS3-pm] Pharmacotherapies (Cancer) 3

[26PS3-pm16S] Novel drug therapy targeting NF-kB signal for triple-negative breast cancer patients with loss of CYLD expression

Password